loadpatents
name:-0.018522024154663
name:-0.0086190700531006
name:-0.0058200359344482
GAUDELLI; Nicole Patent Filings

GAUDELLI; Nicole

Patent Applications and Registrations

Patent applications and USPTO patent grants for GAUDELLI; Nicole.The latest application filed is for "compositions and methods for treating hemoglobinopathies".

Company Profile
4.5.14
  • GAUDELLI; Nicole - Cambridge MA
  • Gaudelli; Nicole - Belmont MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compositions And Methods For Treating Hemoglobinopathies
App 20220235347 - SLAYMAKER; Ian ;   et al.
2022-07-28
Adenosine Deaminase Base Editors And Methods Of Using Same To Modify A Nucleobase In A Target Sequence
App 20220170027 - GAUDELLI; Nicole ;   et al.
2022-06-02
Compositions and methods for treating hemoglobinopathies
Grant 11,344,609 - Slaymaker , et al. May 31, 2
2022-05-31
Nucleobase Editors Having Reduced Off-target Deamination And Methods Of Using Same To Modify A Nucleobase Target Sequence
App 20220136012 - GAUDELLI; Nicole ;   et al.
2022-05-05
Compositions And Methods For Treating Glycogen Storage Disease Type 1a
App 20220127594 - GAUDELLI; Nicole ;   et al.
2022-04-28
Splice Acceptor Site Disruption Of A Disease-associated Gene Using Adenosine Deaminase Base Editors, Including For The Treatment Of Genetic Disease
App 20220098593 - GAUDELLI; Nicole ;   et al.
2022-03-31
Nucleobase Editors Having Reduced Non-target Deamination And Assays For Characterizing Nucleobase Editors
App 20220098572 - SLAYMAKER; Ian ;   et al.
2022-03-31
Adenosine deaminase base editors and methods of using same to modify a nucleobase in a target sequence
Grant 11,155,803 - Gaudelli , et al. October 26, 2
2021-10-26
Adenosine Nucleobase Editors And Uses Thereof
App 20210317440 - LIU; David R. ;   et al.
2021-10-14
Compositions and methods for treating hemoglobinopathies
Grant 11,142,760 - Slaymaker , et al. October 12, 2
2021-10-12
Multi-effector Nucleobase Editors And Methods Of Using Same To Modify A Nucleic Acid Target Sequence
App 20210277379 - Gaudelli; Nicole ;   et al.
2021-09-09
Compositions And Methods For Treating Hemoglobinopathies
App 20210261955 - SLAYMAKER; Ian ;   et al.
2021-08-26
Compositions And Methods For Treating Hemoglobinopathies
App 20210252118 - SLAYMAKER; Ian ;   et al.
2021-08-19
Adenosine Deaminase Base Editors And Methods Of Using Same To Modify A Nucleobase In A Target Sequence
App 20210130805 - GAUDELLI; Nicole ;   et al.
2021-05-06
Adenosine nucleobase editors and uses thereof
Grant 10,947,530 - Liu , et al. March 16, 2
2021-03-16
Uses Of Adenosine Base Editors
App 20200399626 - Liu; David R. ;   et al.
2020-12-24
Adenosine Nucleobase Editors And Uses Thereof
App 20190093099 - Liu; David R. ;   et al.
2019-03-28
Adenosine nucleobase editors and uses thereof
Grant 10,113,163 - Liu , et al. October 30, 2
2018-10-30
Adenosine Nucleobase Editors And Uses Thereof
App 20180073012 - Liu; David R. ;   et al.
2018-03-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed